Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Insulin Resistance × Tablets × Genitourinary × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Urinary Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Localized Prostate Cancer 1 Insulin Resistance 1 Head and Neck Neoplasms 1 Erectile Dysfunction 1 Carcinoma, Renal Cell 1 Adenocarcinoma of Lung 1

Interventions

Pioglitazone 3 Zoledronic Acid 1 Tablets 1 Health Planning Guidelines 1 Exercise 1 Endurance Training 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

St. Louis University

Phase EARLY_PHASE1 Withdrawn

Insulin Resistance, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡